Dystonia and mitochondrial disease: the movement disorder connection revisited in 900 genetically diagnosed patients
Journal of Neurology · 2024-07 · 271 (7) · 4685-4692
DOI: 10.1007/s00415-024-12447-5 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Neurology, online erschienen am 22.05.2024. Verfasst von Elisabetta Indelicato und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, Technical University of Munich, School of Medicine, Munich, Germany. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Dystonia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technische Universität München.
Abstract (Originalsprache)
Dystonia is characterized by excessive muscle contractions leading to abnormal posturing or movements, typically worsening with voluntary action and overflow muscle activation [ 1 ]. Dystonia can arise at any age and affect virtually any muscle [ 1 ]. The disease often co-occurs in combination with other movement disorders or additional neurological signs, resulting in a wide range of clinical outcomes [ 2 ]. Due to its puzzling pathophysiology, dystonia represents one of the core topics in movement disorders research [ 3 ]. High-throughput DNA sequencing has unveiled a strong genetic background for this condition [ 4 ], and has raised a number of novel questions, such as why dystonia-linked genes are implicated in multiple seemingly unrelated pathways [ 3 ]. These comprise but are not limited to a variety of metabolic processes, cellular ion handling, DNA binding and replication, signal transduction, neurotransmitter turnover, protein folding and intracellular trafficking [ 3 ]. This heterogeneous pathophysiology is consistent with a view of dystonia as a network disorder that is not associated with changes in a single neural pathway, but may result from disturbances in multiple regions of the nervous system [ 3 ]. In contrast to Parkinson’s disease [ 5 ], a pathophysiological link between monogenic dystonias and the far more frequent ‘idiopathic’ adult-onset isolated dystonias is missing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Human Genetics, Technical University of Munich, School of Medicine, Munich, Germany.
- Institute of Neurogenomics, Helmholtz Munich, Deutsches Forschungszentrum Für Gesundheit Und Umwelt (GmbH), Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
- Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
- Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
- Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, 02115, USA.
- Department of Neurology, P. J. Safarik University, Kosice, Slovakia.
Förderung
- Technische Universität München
Zitieren
APA
Indelicato, E., Schlieben, L. D., Stenton, S. L., Boesch, S., Skorvanek, M., Necpal, J., Jech, R., Winkelmann, J., Prokisch, H., & Zech, M. (2024). Dystonia and mitochondrial disease: the movement disorder connection revisited in 900 genetically diagnosed patients. Journal of Neurology, 271(7), 4685-4692. https://doi.org/10.1007/s00415-024-12447-5
Vancouver
Indelicato E, Schlieben LD, Stenton SL, Boesch S, Skorvanek M, Necpal J, et al. Dystonia and mitochondrial disease: the movement disorder connection revisited in 900 genetically diagnosed patients. Journal of Neurology. 2024;271(7):4685-4692. doi:10.1007/s00415-024-12447-5
BibTeX
@article{Indelicato2024,
author = {Indelicato, Elisabetta and Schlieben, Lea D and Stenton, Sarah L and Boesch, Sylvia and Skorvanek, Matej and Necpal, Jan and Jech, Robert and Winkelmann, Juliane and Prokisch, Holger and Zech, Michael},
title = {Dystonia and mitochondrial disease: the movement disorder connection revisited in 900 genetically diagnosed patients},
journal = {Journal of Neurology},
year = {2024},
volume = {271},
number = {7},
pages = {4685--4692},
doi = {10.1007/s00415-024-12447-5}
}
EUVIMED